What were Saakshi Medtech & Panels Ltd's latest quarterly results?
Saakshi Medtech & Panels Ltd's latest quarterly results (Mar 2026) show
- PAT Growth YoY: +500.0%
- Revenue Growth YoY: +18.8%
- Operating Margin: 20.0%
In , Saakshi Medtech & Panels Ltd (Diversified) is outperforming Nifty 500 with +53.0% relative strength.
Weekly presence in the outperformers list. Green = beating Nifty 500 by 10%+ that week.
Based on publicly available financial data. This is educational research, not investment advice.
Saakshi Medtech & Panels Ltd's latest quarterly results (Mar 2026) show
Saakshi Medtech & Panels Ltd's current PE ratio is 43.8x.
Saakshi Medtech & Panels Ltd's price-to-book ratio is 4.9x.
Saakshi Medtech & Panels Ltd's fundamental strength based on key financial ratios
Saakshi Medtech & Panels Ltd has a debt-to-equity ratio of N/A.
Saakshi Medtech & Panels Ltd's return ratios over recent years
Saakshi Medtech & Panels Ltd's operating cash flow is positive (FY2026).
Saakshi Medtech & Panels Ltd currently does not pay a significant dividend (yield 0.00%).
Saakshi Medtech & Panels Ltd's shareholding pattern (Mar 2026)
Saakshi Medtech & Panels Ltd's promoter holding has increased recently.
Saakshi Medtech & Panels Ltd has been outperforming Nifty 500 for 1 consecutive week, indicating early-stage outperformance.
Saakshi Medtech & Panels Ltd is a new entry this week — it just started outperforming Nifty 500. New entries are worth monitoring for follow-through.
Based on quantitative research signals, here is why Saakshi Medtech & Panels Ltd may be worth studying
Saakshi Medtech & Panels Ltd investment thesis summary:
Saakshi Medtech & Panels Ltd's forward outlook based on current data signals
The above FAQs are generated from publicly available earnings data and conference call transcripts. This is educational research only. Sector Alpha is not SEBI registered and does not provide investment advice.